ProfileGDS5678 / 1456913_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 44% 45% 45% 45% 45% 43% 42% 45% 45% 45% 45% 46% 46% 45% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.0592144
GSM967853U87-EV human glioblastoma xenograft - Control 23.0496945
GSM967854U87-EV human glioblastoma xenograft - Control 33.0455645
GSM967855U87-EV human glioblastoma xenograft - Control 42.9968245
GSM967856U87-EV human glioblastoma xenograft - Control 53.0136145
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.0827843
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.0447742
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.0327245
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.0294945
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.0437345
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.0319845
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.0324246
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.0803746
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.0388945